Results 211 to 220 of about 89,178 (311)
Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis. [PDF]
Wu Q +15 more
europepmc +1 more source
The E2/T ratio showed an independent and positive association with the risk of MASLD in male patients with type 2 diabetes mellitus, potentially reflecting its link with inflammation. The E2/T ratio may serve as a simple and practical indicator for assessing MASLD risk in this population.
Meng‐Han Li +4 more
wiley +1 more source
Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China. [PDF]
Wang C, Lin X, Liu J, Zhang Y, You R.
europepmc +1 more source
The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women
Dolores Sánchez‐Rodríguez +11 more
openalex +2 more sources
The BMDs of several body regions are associated with age and sex, with variations in the rate of change, age at first change, and age‐related trends depending on the anatomical site and sex. The BMDs of L1 and L2 are generally significantly lower than those of L3 and L4.
Jia‐Jun Zhang +4 more
wiley +1 more source
BPAG1 promotes osteoclastogenesis and postmenopausal osteoporosis via activating ERK signaling pathway. [PDF]
Zhang Y +4 more
europepmc +1 more source
Exploring neuronal mechanisms of osteosarcopenia in older adults
Abstract figure legend The mechanosensitive osteocytic network within the bone matrix acts as a receptor and plays a crucial role in the functional adaptation of bone to mechanical loading. Through mechanotransduction, osteocytes convert mechanical impulses into electrical signals, which are transmitted via afferent nerves to sympathetic preganglionic ...
Ilhan Karacan, Kemal Sıtkı Türker
wiley +1 more source
Nanoparticles coated with osteoblast-like cell membranes as curcumin delivery vehicles for targeted postmenopausal osteoporosis therapy. [PDF]
Li Q +6 more
europepmc +1 more source

